Camouflages
lCAMOUFLAGES
Covermark classic foundation(Derma UK Ltd)
15 ml (ACBS).NHS indicative price = £ 11. 86
Covermark finishing powder(Derma UK Ltd)
25 gram (ACBS).NHS indicative price = £ 11. 86
Dermablend Dermasmooth Corrective Foundation(Vichy)
30 ml.No NHS indicative price available
Dermacolor body camouflage(Kryolan UK Ltd)
50 ml.NHS indicative price = £ 8. 94
Dermacolor camouflage(Kryolan UK Ltd)
30 gram.NHS indicative price = £ 11. 00
Dermacolor fixing powder(Kryolan UK Ltd)
60 gram (ACBS).NHS indicative price = £ 9. 85
Keromask finishing powder(Bellava Ltd)
20 gram (ACBS).NHS indicative price = £ 6. 07
Keromask masking cream(Bellava Ltd)
15 ml (ACBS).NHS indicative price = £ 6. 07
Veil cover cream(Thomas Blake Cosmetic Creams Ltd)
19 gram (ACBS).NHS indicative price = £ 22 .42 44gram (ACBS).NHS
indicative price = £ 33 .3 570gram (ACBS).NHS indicative price = £ 42. 10
Veil finishing powder(Thomas Blake Cosmetic Creams Ltd)
35 gram (ACBS).NHS indicative price = £ 24. 5810 Sun protection and
photodamage
Sunscreen
Sunscreen preparations
Solar ultraviolet irradiation can be harmful to the skin. It is
responsible for disorders such aspolymorphic light eruption,
solar urticaria,and it provokes the variouscutaneous
porphyrias.It also provokes (or at least aggravates) skin
lesions oflupus erythematosusand may aggravate some other
dermatoses.Certain drugs, such as demeclocycline,
phenothiazines, or amiodarone, can cause photosensitivity.
All these conditions (as well assunburn) may occur after
relatively short periods of exposure to the sun. Solar
ultraviolet irradiation may provoke attacks of recurrent
herpes labialis (but it is not known whether the effect of
sunlight exposure is local or systemic).
The effects of exposure over longer periods includeageing
changesand more importantly the initiation ofskin cancer.
Solar ultraviolet radiation is approximately 200 – 400 min
wavelength. The medium wavelengths ( 290 – 320 nm, known
as UVB) cause sunburn. The long wavelengths ( 320 – 400 nm,
known as UVA) are responsible for manyphotosensitivity
reactionsandphotodermatoses. Both UVA and UVB
contribute to long-termphotodamageand to the changes
responsible forskin cancerand ageing.
Sunscreen preparations contain substances that protect
the skin against UVA and UVB radiation, but they are no
substitute for covering the skin and avoiding sunlight.
Protective clothing and sun avoidance (rather than the use of
sunscreen preparations) are recommended for children
under 6 months of age.
The sun protection factor (SPF, usually indicated in the
preparation title) provides guidance on the degree of
protection offered against UVB; it indicates the multiples of
protection provided against burning, compared with
unprotected skin; for example, an SPF of 8 should enable a
child to remain 8 times longer in the sun without burning.
However, in practice users do not apply sufficient sunscreen
product and the protection is lower than that found in
experimental studies. Some manufacturers use a star rating
system to indicate the protection against UVA relative to
protection against UVB for sunscreen products. However,
the usefulness of the star rating system remains
controversial. The EU Commission (September 2006 )has
recommended that the UVA protection factor for a sunscreen
should be at least one-third of the sun protection factor
(SPF); products that achieve this requirement will be labelled
with a UVA logo alongside the SPF classification.
Preparations that also contain reflective substances, such as
titanium dioxide, provide the most effective protection
against UVA.
Sunscreen preparations may rarely cause allergic
reactions.
For optimum photoprotection, sunscreen preparations
should be appliedthicklyandfrequently(approximately
2 hourly). In photodermatoses, they should be used from
spring to autumn. As maximum protection from sunlight is
desirable, preparations with the highest SPF should be
prescribed.Ingredient nomenclature in sunscreen
preparationsrINN INCI
amiloxate isoamylp-methoxycinnamate
avobenzone butyl methoxydibenzoylmethane
bemotrizinol bis-ethylhexyloxyphenol
methoxyphenyl triazine
bisoctrizole methylene bis-benzotriazolyl
tetramethylbutylphenol
ecamsule terephthalylidene dicamphor
sulfonic acid
ensulizole phenylbenzimidazole sulfonic acid
enzacamene 4 -methylbenzylidene camphor
octinoxate octyl (orethylhexyl)
methoxycinnamate
octocrilene octocrylene
oxybenzone benzophenone- 3
The European Commission Cosmetic Products Regulation (EC)
1223 / 2009 requires the use of INCI (International Nomenclature
of Cosmetic Ingredients) for cosmetics and sunscreens. This table
includes the rINN and the INCI synonym for the active ingredients
of sunscreen preparations in the BNFCBorderline substances
Anthelios®XL SPF 50 + Melt-in cream;Sunsense®Ultra;
Uvistat®Lipscreen SPF 50 ; andUvistat®Suncream SPF 30
and 50 (seeBorderline substances) cannot be prescribed on
the NHS except for skin protection against ultraviolet
radiation in abnormal cutaneous photosensitivity resulting
from genetic disorders or photodermatoses, including
vitiligo and those resulting from radiotherapy; chronic or
recurrent herpes simplex labialis. Preparations with SPF less
than 30 should not normally be prescribed.Photodamage
Overview
Actinic keratoses occur very rarely in healthy children;
actinic cheilitis may occur on the lips of adolescents
following excessive sun exposure.
Diclofenac gel (Solaraze®) and topical preparations of
fluorouracil are licensed for the treatment of actinic
keratoses but they are not licensed for use in children.
In children with photosensitivity disorders, such as
erythropoietic protoporphyria, specialists may useBNFC 2018 – 2019 Sun protection and photodamage 765
Skin13